Tag results:

hematopoietic stem cells

Cytokine Combinations for Human Blood Stem Cell Expansion Induce Cell Type- and Cytokine-Specific Signaling Dynamics

[Blood] By combining fluorescent biosensors with time-lapse imaging and microfluidics, researchers measured the activity of the extracellular signal-regulated kinase pathway over time in live single human umbilical cord blood HSCs and multipotent progenitor cells.

The Therapeutic Potential of Hematopoietic Stem Cells in Bone Regeneration

[Tissue Engineering Part B-Reviews] Investigators highlight the influence of hematopoeitic stem cells in the bone repair process, mainly through the promotion of osteogenesis and angiogenesis at the bone injury site.

Biased Action of the CXCR4-Targeting Drug Plerixafor Is Essential for Its Superior Hematopoietic Stem Cell Mobilization

[Communications Biology] Scientists showed that while AMD11070 acts as a full antagonist, plerixafor acts biased by stimulating Ī²-arrestin recruitment while fully antagonizing G protein.

Hematopoietic versus Leukemic Stem Cell Quiescence: Challenges and Therapeutic Opportunities

[Blood Reviews] Scientists summarize the current knowledge on the biochemical characteristics of quiescent hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs), the intracellular signaling pathways and the niche-driven mechanisms that control quiescence and the key differences between HSC- and LSC-quiescence.

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

[New England Journal of Medicine] Scientists treated 50 patients with Severe combined immunodeficiency due to adenosine deaminase (ADA) with an investigational gene therapy composed of autologous CD34+ hematopoietic stem and progenitor cells transduced ex vivo with a self-inactivating lentiviral vector encoding human ADA.

Genetically Edited CD34+ Cells Derived from Human iPS Cells In Vivo but Not In Vitro Engraft and Differentiate into HIV-Resistant Cells

[Proceedings of the National Academy of Sciences of the United States of America] CD34+ cells derived in vitro from induced pluripotent stem (iPS) cells genetically modified to carry the CCR5Ī”32 mutant alleles did not engraft in humanized immunodeficient mice.

Popular